Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 33.65
+0.50 (1.51%)
Apr 29, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.62 billion as of April 28, 2026. Its market cap has increased by 4.41% in one year.
Market Cap
4.62B
Enterprise Value
6.21B
Revenue
1.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
33.65
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.62B, an increase of 574.60%. That is a compound annual growth rate of 9.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmosa Biopharm | 4.91B |
| UnicoCell Biomed | 5.14B |
| Steminent Biotherapeutics | 5.20B |
| Senhwa Biosciences | 4.55B |
| Panion & Bf Biotech | 5.43B |
| ACRO Biomedical | 4.29B |
| OBI Pharma | 4.14B |
| Formosa Pharmaceuticals | 4.11B |